# The Efficacy and Safety Study of Clindamycin Palmitate Hydrochloride Dispersible Tablet Treatment of Bacterial Vaginosis

> **NCT03080740** · PHASE4 · UNKNOWN · sponsor: **Guangzhou Yipinhong Pharmaceutical CO.,LTD** · enrollment: 300 (estimated)

## Conditions studied

- Bacterial Vaginosis

## Interventions

- **DRUG:** Clindamycin palmitate hydrochloride dispersible tablet
- **DRUG:** Metronidazole Tablet

## Key facts

- **NCT ID:** NCT03080740
- **Lead sponsor:** Guangzhou Yipinhong Pharmaceutical CO.,LTD
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-07
- **Primary completion:** 2017-07
- **Final completion:** 2017-12
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2017-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03080740

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03080740, "The Efficacy and Safety Study of Clindamycin Palmitate Hydrochloride Dispersible Tablet Treatment of Bacterial Vaginosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03080740. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*